Consumers Are Replacing Pharmaceuticals With Medical Marijuana

The Fresh Toast

Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. Cannabis Medical Marijuana News opioids pharmaceuticals

BBC Report: EU Approves , “Epidyolex” GW Pharmaceuticals

Cannabis Law Report

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.

Aurora Cannabis and CTT Pharmaceutical Launch Sublingual Cannabis Wafers

Cannabis Life Network

8, 2019 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC | CTTH) announced […].

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl

Cannabis Law Report

TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC.

Benchmark Signs A Strategic Cooperation With China-Based Zejiang Yatai Pharmaceutical

Canna Newswire

To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co.,

International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products

Cannabis Law Report

Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. ICC International Cannabis Corp. CSE: WRLD.U)(FWB:

International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products

Cannabis Law Report

Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form.

Benchmark Signs Definitive Investment Cooperation Agreement with China-Based Zhejiang Yatai Pharmaceutical

Canna Newswire

CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S.

Leaf Science

study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. The post New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S. A new U.S.

Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc

Cannabis Law Report

Forbes report.

Canadian Company Signs “Definitive Agreement” With China-based Zhejiang Yatai Pharmaceutical Co., Ltd

Cannabis Law Report

CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

UK Opinion Piece: The Pharmaceutical Journal – The bar must not be lowered for medical cannabis

Cannabis Law Report

There have been calls to loosen regulations around medical cannabis to increase access for those who need it, but the government must resist and view cannabis with the same scrutiny as any other new medicine. Read all at ( paywall) [link]. Medical Cannabis News

Thailand: Press Release Thailand Govt Pharma Organization “Pharmaceutical Organization, Department of Medical Cooperation, Research on Medical Marijuana Extracts For cancer patients with neurodegenerative epilepsy And nervous pain”

Cannabis Law Report

Press Release: Thailand Government Pharmaceutical Organization. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee. Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization.

Australia’s MGC Pharmaceuticals finally gets cannabis cultivation research licence from the Australian Office of Drug Control.

Cannabis Law Report

Here’s the press release. The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research.

Dr. Sanjay Gupta: Researchers Are Focused On Treating Autism With Marijuana

The Fresh Toast

Cannabis Featured Medical Marijuana News autism CBD oil Epilepsy GW Pharmaceuticals Sanjay GuptaLeading marijuana researchers now believe a cannabis compound could treat autism symptoms.

Why The US Has Higher Drug Prices Than Other Countries

The Fresh Toast

can refocus its regulatory approach to pharmaceuticals, adapted from the one used in Europe, to better connect the value prescription drugs provide and their price. Cannabis Medical Marijuana News RX Affordable Care Act Donald Trump drugs FDA Germany health care opioids pharmaceuticals

The Truth About CBD

Nature's Way Medicine

Alternative Medicine cannabis education industry Logical Fallacies medical marijuana medicine News Pharmaceuticals Science-Based Medicine Skepticism about cbd dr. roman fake placebo skeptic skeptical skepticism thc truthIt's not easy gathering my wits and going public about this.

CBD 87

Innovative Treatment for Seizures Released by Nature’s Grace and Wellness & JC Pharma Inc

Canna Newswire

MEDICAL CANNABIS PHARMACEUTICALSTwo Health and Wellness Powerhouses Collaborate to Help Those Suffering from Seizures Through an Innovative and Fast-Acting Intranasal Spray Solution. CHICAGO – July 11, 2019 / Canna Newswire / – Nature’s Grace and Wellness & JC Pharma, Inc.

Opioids and Medical Cannabis: An Update on the Latest Information

Medical Marijuana 411

Cannabis Science Decriminalization Legalization Medical Marijuana 411 Politics Prohibition Addiction Opioids PharmaceuticalAmerica is in the throes of a major crisis. Opioid addiction has taken over many parts of the country and is taking a number of lives daily. The opioid crisis is at its breaking point right now. More people are spending time in hospitals or losing their lives to opioid overdose than ever before. According to the National Institute on Read Article.

Portugal Shoots Down Recreational Proposals As Medicinal Weed Goes Live

Cannabis Law Report

Medicinal cannabis was legalised in portugal in June 2018 by Parliament, however only one cannabis-based medication is legal in Portugal; Sativex, produced by British firm GW Pharmaceuticals. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 65

The Evolving Regulatory Status of Cannabidiol

Project CBD

Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.

Cannabinoids for Scleroderma

Project CBD

Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials.

Synthetic CBD and Solvents in Epidiolex?

Cannabis Life Network

GW Pharmaceuticals has been creating unusual blends of clinical cannabis for over two decades. Blog Featured Health Marijuana News Science Technology abnormal cbd CBD Epidiolex ethanol gpr GW Pharmaceuticals synthetic cbd

The Evolving Regulatory Status of Cannabidiol

Project CBD

Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.

When is CBD Legal and When Isn't It?

Project CBD

Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.

10 Tips for Buying CBD Oil

Project CBD

In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy.

Oil 266

CBD & Cannabis for Pets in Pain

Project CBD

Conventional pharmaceuticals commonly used to treat pain sometimes have a negative impact on the immune system, GI tract, liver, and kidneys.

Pets 273

10 Tips for Buying Hemp-Derived CBD Products

Project CBD

How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered.

DEA 216

Today’s Answer of the Day

TheAnswerPage

There is limited to moderate evidence to suggest that dronabinol, a synthetic pharmaceutical preparation of delta-9-tetrahydrocannabinol, may be effective in stimulating appetite and weight gain among patients suffering from HIV wasting syndrome.

The Potential Of CBD And Cannabis Within The Anxiety And Autism Community

The Fresh Toast

With the stigma of cannabis fading by the day, more families are exploring treatments that are more accessible and less pharmaceutical. Continue reading The Potential Of CBD And Cannabis Within The Anxiety And Autism Community at The Fresh Toast.

Five Golden Rules When Buying CBD Oil

LIWTS

To such an extent that millions have already swapped their traditional pharmaceuticals for this high-power, low-risk organic […]. As the cannabis revolution continues to sweep the world, the wonders of CBD are becoming common knowledge.

Oil 95

New Study Aims To Learn If Cannabis Can Help Treat Autism

MedicalJane

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. ” This isn’t the first time GW Pharmaceuticals is making waves in the cannabis industry.

Introducing MGC Nutraceuticals

MGC Pharma

MXC’s fourth division: MGC Nutraceuticals MGC Pharmaceuticals will be taking its first step into the world of nutraceuticals with the creation of our new brand, MGC Nutraceuticals.

UPDATE: CannEpil™ production has officially commenced

MGC Pharma

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. Thursday March 29 was a day of celebration on MGC Pharma’s timeline as we announced the commencement of production for the first batch of CannEpil™. CannEpil™?—?CBD-based

Australia’s MGC launches Slovenian medical cannabis research project

Cannabis Law Report

ASX-listed MGC Pharmaceuticals has partnered with the Slovenian Institute of Hop Research and Brewing, or “IHPS”, to carry out a ground-breaking, large-scale research project on the use of cannabis for medical purposes.

Father of Cannabis Research Creates More Potent, Synthetic Versions of Cannabinoids 

Freedom Leaf

EPM plans to license the synthetic compounds to pharmaceutical companies for use in drug development and clinical research. . Critics of the pharmaceutical industry may take the news as proof that big movers in government and business are determined to dominate the cannabis space. .